Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRAX | ONCO | NCNA | ||
| Company | Virax Biolabs Group Limited | Onconetix Inc | Nucana Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.1810 | 1.6000 | 1.5400 | ||
| High | 0.2096 | 1.6686 | 1.6667 | ||
| Low | 0.1610 | 1.3000 | 1.4233 | ||
| Latest | 0.1740 | 1.5200 | 1.6300 | ||
| Change | -0.0240 | -0.3552 | +0.0900 | ||
| % Change | -12.12% | -18.94% | +5.84% | ||
| Volume | 2,444,000 | 966,400 | 18,800 | ||
| 20-Day Average Volume | 12,663,895 | 3,909,422 | 52,525 | ||
| Previous Close | 0.1980 | 1.8752 | 1.5400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1883 | 2.5249 | 1.7200 | ||
| 20-Day Raw Stochastic | 17.12% | 6.29% | 34.09% | ||
| 20-Day Relative Strength | 42.09 | 34.86 | 38.30 | ||
| Weighted Alpha | -86.96 | -93.59 | -89.75 | ||
| Today's Opinion | 96% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 80% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.46% since 03/26/26 | -52.80% since 03/26/26 | +10.14% since 03/26/26 | ||
| Low | 0.1521 on 03/27/26 | 1.1700 on 03/30/26 | 1.3300 on 03/30/26 | ||
| High | 0.2800 on 03/31/26 | 6.7300 on 03/27/26 | 1.6667 on 04/02/26 | ||
| 1-Month | |||||
| %Chg | -21.02% since 03/02/26 | -53.24% since 03/02/26 | -24.19% since 03/02/26 | ||
| Low | 0.1521 on 03/27/26 | 1.1700 on 03/30/26 | 1.3300 on 03/30/26 | ||
| High | 0.2800 on 03/31/26 | 6.7300 on 03/27/26 | 2.2200 on 03/05/26 | ||
| 3-Month | |||||
| %Chg | -54.69% since 01/02/26 | -81.12% since 01/02/26 | -55.22% since 01/02/26 | ||
| Low | 0.1521 on 03/27/26 | 1.1700 on 03/30/26 | 1.3300 on 03/30/26 | ||
| High | 0.4384 on 01/06/26 | 11.5000 on 01/20/26 | 3.8100 on 01/13/26 | ||
| 6-Month | |||||
| %Chg | -71.50% since 10/02/25 | -90.35% since 10/02/25 | -64.79% since 10/02/25 | ||
| Low | 0.1521 on 03/27/26 | 1.1700 on 03/30/26 | 1.3300 on 03/30/26 | ||
| High | 0.8700 on 12/03/25 | 20.9500 on 10/09/25 | 7.2200 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 860 | 1,230 | 47 | ||
| Shares Outstanding, K | 4,342 | 656 | 30 | ||
| Annual Sales | 10,000 | 820,000 | 0 | ||
| Annual Net Income | -6,060,000 | -14,030,000 | -38,710,000 | ||
| Last Quarter Sales | N/A | 300,000 | 0 | ||
| Last Quarter Net Income | N/A | 5,670,000 | -3,010,000 | ||
| 60-Month Beta | 1.61 | 3.63 | 1.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 62.90 on 03/13/26 | -1.47 on 03/19/26 | ||
| Latest Earnings Date | 07/01/26 | 06/11/26 | 06/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.01 | 0.00 | ||